Literature DB >> 2203135

Colony stimulating factor occurs in both inflammatory and noninflammatory synovial fluids.

J B Smith1, M H Bocchieri, J B Smith1, L Sherbin-Allen, J L Abruzzo.   

Abstract

Synovial fluids (SF) from patients with osteoarthritis (OA) and rheumatoid arthritis (RA) and various other arthritides were examined for the presence of colony stimulating factors (CSF). CSF was found in 7 of 13 (54%) SF from OA patients and in 8 of 12 (67%) SF from RA patients. It was also found in SF from patients with other arthropathies including 5 of 5 samples from patients with septic arthritis. Inhibition studies employing monospecific antisera indicated that in both RA and OA, CSF was of the macrophage type (M-CSF). While CSF was found in both inflammatory and noninflammatory effusions, significantly greater numbers of colonies were stimulated by RA SF than by OA SF and in general greater numbers of colonies correlated with higher SF leukocyte counts. Our data suggest that CSF as well as other cytokines may be involved in the perpetuation of joint destruction that occurs in various rheumatological conditions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2203135     DOI: 10.1007/bf02274828

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  21 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid.

Authors:  P Miossec; C A Dinarello; M Ziff
Journal:  Arthritis Rheum       Date:  1986-04

Review 3.  Interleukin 1: an immunological perspective.

Authors:  S K Durum; J A Schmidt; J J Oppenheim
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

4.  Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents.

Authors:  G DiPasquale; R Caccese; R Pasternak; J Conaty; S Hubbs; K Perry
Journal:  Proc Soc Exp Biol Med       Date:  1986-11

5.  The detection and initial characterization of colony-stimulating factors in synovial fluid.

Authors:  D J Williamson; C G Begley; M A Vadas; D Metcalf
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

6.  Tumour necrosis factor in synovial exudates.

Authors:  F S Di Giovine; G Nuki; G W Duff
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

7.  Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis.

Authors:  A Fontana; H Hengartner; E Weber; K Fehr; P J Grob; G Cohen
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

8.  Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids.

Authors:  A M Nouri; G S Panayi; S M Goodman
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

9.  Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint.

Authors:  E R Pettipher; G A Higgs; B Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

10.  Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis.

Authors:  G S Firestein; W D Xu; K Townsend; D Broide; J Alvaro-Gracia; A Glasebrook; N J Zvaifler
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  6 in total

1.  Stimulation of osteoclast formation by inflammatory synovial fluid.

Authors:  Iannis E Adamopoulos; Lynett Danks; Ichiro Itonaga; Rachel M Locklin; Afsie Sabokbar; David J P Ferguson; Nicholas A Athanasou
Journal:  Virchows Arch       Date:  2006-04-21       Impact factor: 4.064

2.  Cytotoxic effects of Kingella kingae outer membrane vesicles on human cells.

Authors:  R Maldonado; R Wei; S C Kachlany; M Kazi; N V Balashova
Journal:  Microb Pathog       Date:  2011-04-02       Impact factor: 3.738

3.  Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis.

Authors:  Y Fujikawa; A Sabokbar; S Neale; N A Athanasou
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

4.  Synovial macrophage-osteoclast differentiation in inflammatory arthritis.

Authors:  L Danks; A Sabokbar; R Gundle; N A Athanasou
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

5.  Microheterogeneity of acute phase proteins in patients with clinically active and clinically nonactive osteoarthritis.

Authors:  P Hrycaj; T Stratz; C Kovac; P Mennet; W Müller
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

6.  Measurement of colony-stimulating factors in synovial fluid: potential clinical value.

Authors:  A L Bell; M K Magill; W R McKane; F Kirk; A E Irvine
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.